International regulatory convergence discussed in India
Vladislav Shestakov, Director of the FSI “State Institute of Drugs and Good Practices” of the Russian Ministry of Industry and Trade, has taken part in the Global Regulators Conclave that has kicked off today in India.
In his address at the thematic discussion on International Regulatory Convergence to Promote Accessibility and Affordability of Quality Medicines, Vladislav Shestakov has highlighted that the mutual trust formation among regulatory systems of nations is widely debated at different levels – from international conferences to highly specialised working groups and expert councils.
“Convergence and mutual recognition is a multistage process that comprises several steps. We believe the creation of a global association of pharmaceutical inspectorates is one of such steps, i.e. an association of representatives of pharmaceutical inspectorates that would provide elaboration of a mechanism for mutual assessment of the regulatory system of the members of the Association, experience exchange, strengthening of mutual trust, rendering mutual assistance in developing regulatory systems and identifying best practices, principles, and approaches to inspections”, Director of the FSI “SID and GP” marked in his
Concluding his speech, Vladislav Shestakov expressed his willingness to discuss proposals from various countries whose representatives would like to join the working group to generate and elaborate all the aspects related to such a global association of pharmaceutical inspectorates.
- Cooperation issues in the pharmaceutical industry and healthcare system were discussed at the Russia-Africa Summit
- International cooperation discussed at the Drug Safety Forum
- Transformation of medical education and training of highly qualified personnel discussed at the Uzbek-Russian Medical Forum
- Memorandum of Cooperation signed between the Eurasian Academy of Good Practices, State Center for Expertise and Standardization of Medicines, Medical Devices and Medical Equipment (Uzbekistan), and Rusatom Healthcare JSC
- The prospects for the development of cooperation between Russia and Saudi Arabia in the pharmaceutical industry were discussed as part of the business mission Made in Russia + INNOPROM